News and features - SynBioBeta

Synthetic biology news

SynBioBeta is the synthetic biology industry’s leading source for news, trends, profiles and analysis. We talk to the innovators who are using engineered biology to revolutionize agriculture, medicine, energy, food, consumer products, chemicals and materials. Our readers gain valuable insights on synthetic biology innovation, investment, and opportunities.

Institute of Systems and Synthetic Biology

The five hottest synthetic biology job markets in the world

Although the majority of the synthetic biology market is concentrated in North America and Europe, the synthetic biology landscape is growing worldwide — with some of the fastest growing areas developing outside...

The top 10 skills synthetic biologists will need for 2019

In synthetic biology, it’s not only what you measure, but how you share it.

Scientists and engineers are doing amazing things with synthetic biology. Amazing at multiple levels: natural subsystems are repurposed, extensively engineered, and multiple interactive elements are integrated into...

Synthetic biology and reproducibility meet on the Internet (of Things)

Measuring what matters: A Q&A with Agilent’s Darlene Solomon

New cell-free expression system runs on linear DNA

Before synthetic biology can retool the economy, save the planet, or help put people on Mars, it’s going to have to become significantly easier to use. Take computers. If you wanted to do anything useful with a computer...

How sweet it is: The next generation of natural, zero-calorie sweeteners

The future of DNA synthesis

DNA is the blueprint of life, as well as the cornerstone of the synthetic biology industry — the core of the design-build-test cycle that makes custom organisms and the things they produce. So it’s fitting that...

These 98 synthetic biology companies raised $3.8 billion in 2018

CRISPR is stuck, and this company can fix it

Zymergen raises $400M+ to deliver AI-enabled biology to global bio-based industry

Zymergen announced a $400+ million Series C funding round in support of its proprietary technology platform to produce novel and improved molecules to meet global-scale industrial needs. The majority of products used...

Here are 2018’s top articles on SynBioBeta

Four synthetic biology startups to watch in 2019

The bioeconomy is growing at an impressive rate, and doesn’t show signs of slowing. In 2017, 2016 was the year to beat. No problem — the bar was easily set higher than ever, and the community excitedly looked...